New England Journal of Medicine published a clinical update in Research Highlights on 08 Apr 2026. The item focuses on A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia. Review the original article for the full source wording and details.
New England Journal of Medicine published a clinical update in Research Highlights on 08 Apr 2026.
The item focuses on A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia.
Review the original article for the full source wording and details.